Although semi-automated analysis of IHC requires a great degree of standardization and optimization initially, it can achieve a quantitative and reliable output of protein expression on cells in situ, as in quantifying HER2/ER receptors on breast cancer cells in tumors [28–30]. The gene discussed is ERBB2; the disease is breast carcinoma.